Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups

Drug and Alcohol Dependence

Volumn 92, Issue 1-3, 2008, Pages 20-26

  Huang, San Yuan ^a   Lu, Ru Band ^b   Ma, Kuo Hsing ^c   Shy, Mee Jen ^a   Lin, Wei Wen ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Alcohol dependence; Clinical subtypes; Depressive disorder; Norepinephrine transporter gene

Indexed keywords

NORADRENALIN TRANSPORTER;

ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CHINESE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE COURSE; GENE FREQUENCY; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HEALTH; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TAIWAN;

ADULT; AGE OF ONSET; ALCOHOLISM; ALLELES; ANALYSIS OF VARIANCE; ANXIETY; CHINA; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTION BIAS;

EID: 36749094703     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.06.003     Document Type: Article

References (47)

1. Bierut L.J., Dinwiddie S.H., Begleiter H., Crowe R.R., Hesselbrock V., Nurnberger Jr. J.I., Porjesz B., Schuckit M.A., and Reich T. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch. Gen. Psychiatry 55 (1998) 982-988
2. Bruss M., Kunz J., Lingen B., and Bonisch H. Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum. Genet. 91 (1993) 278-280
3. Buchner, A., Faul, F., Erdfelder, E., 1996. G-power: A priori, post hoc, and Compromise Power Analyses for the Macintosh (Version 2.1.1). Trier, University of Trier.
4. Buckland P.R. Genetic association studies of alcoholism-problems with the candidate gene approach. Alcohol Alcohol. (Oxford, Oxfordshire) 36 (2001) 99-103
5. Chang C.C., Lu R.B., Chen C.L., Chu C.M., Chang H.A., Huang C.C., Huang Y.L., and Huang S.Y. Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. J. Psychiatry Neurosci. 32 (2007) 121-128
6. Cloninger C.R., Bohman M., and Sigvardsson S. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Arch. Gen. Psychiatry 38 (1981) 861-868
7. Endicott J., and Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35 (1978) 837-844
8. Harford T.C. Early onset of alcohol use and health problems: spurious associations and prevention. Addiction 98 (2003) 1483-1484
9. Haughey H.M., Kaiser A.L., Johnson T.E., Bennett B., Sikela J.M., and Zahniser N.R. Norepinephrine transporter: a candidate gene for initial ethanol sensitivity in inbred long-sleep and short-sleep mice. Alcohol Clin. Exp. Res. 29 (2005) 1759-1768
10. Hawley R.J., Major L.F., Schulman E.A., and Linnoila M. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs. Arch. Gen. Psychiatry 42 (1985) 1056-1062
11. Hsu Y.P., Loh E.W., Chen W.J., Chen C.C., Yu J.M., and Cheng A.T. Association of monoamine oxidase A alleles with alcoholism among male Chinese in Taiwan. Am. J. Psychiatry 153 (1996) 1209-1211
12. Huang S.Y., Lin W.W., Ko H.C., Lee J.F., Wang T.J., Chou Y.H., Yin S.J., and Lu R.B. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin. Exp. Res. 28 (2004) 374-384
13. Hwang B.H., Wang G.M., Wong D.T., Lumeng L., and Li T.K. Norepinephrine uptake sites in the locus coeruleus of rat lines selectively bred for high and low alcohol preference: a quantitative autoradiographic binding study using [3H]-tomoxetine. Alcohol Clin. Exp. Res. 24 (2000) 588-594
14. Inoue K., Itoh K., Yoshida K., Shimizu T., and Suzuki T. Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Neuropsychobiology 50 (2004) 301-304
15. Jonsson E.G., Nothen M.M., Gustavsson J.P., Neidt H., Bunzel R., Propping P., and Sedvall G.C. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res. 79 (1998) 1-9
16. Kidd K.K. Associations of disease with genetic markers: deja vu all over again. Am. J. Med. Genet. 48 (1993) 71-73
17. Kim C.H., Hahn M.K., Joung Y., Anderson S.L., Steele A.H., Mazei-Robinson M.S., Gizer I., Teicher M.H., Cohen B.M., Robertson D., Waldman I.D., Blakely R.D., and Kim K.S. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proceedings of the National Academy of Sciences of the United States of America, 103 (2006) 19164-19169
18. Kim C.H., Kim H.S., Cubells J.F., and Kim K.S. A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J. Biol. Chem. 274 (1999) 6507-6518
19. Kim H., Lim S.W., Kim S., Kim J.W., Chang Y.H., Carroll B.J., and Kim D.K. Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296 (2006) 1609-1618
20. Klein D.N., Schatzberg A.F., McCullough J.P., Dowling F., Goodman D., Howland R.H., Markowitz J.C., Smith C., Thase M.E., Rush A.J., LaVange L., Harrison W.M., and Keller M.B. Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J. Affect. Disord. 55 (1999) 149-157
21. Kraemer G.W., Lake C.R., Ebert M.H., and McKinney W.T. Effects of alcohol on cerebrospinal fluid norepinephrine in rhesus monkeys. Psychopharmacology (Berl.) 85 (1985) 444-448
22. Lessov-Schlaggar C.N., Pang Z., Swan G.E., Guo Q., Wang S., Cao W., Unger J.B., Johnson C.A., and Lee L. Heritability of cigarette smoking and alcohol use in Chinese male twins: the Qingdao twin registry. Int. J. Epidemiol. 35 (2006) 1278-1285
23. Lu R.B., Lin W.W., Lee J.F., Ko H.C., and Shih J.C. Neither antisocial personality disorder nor antisocial alcoholism is associated with the MAO-A gene in Han Chinese males. Alcohol Clin. Exp. Res. 27 (2003) 889-893
24. Merikangas K.R., Risch N.J., and Weissman M.M. Comorbidity and co-transmission of alcoholism, anxiety and depression. Psychol. Med. 24 (1994) 69-80
25. Merikangas K.R., Stevens D.E., Fenton B., Stolar M., O'Malley S., Woods S.W., and Risch N. Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol. Med. 28 (1998) 773-788
26. Meyer J., Wiedemann P., Okladnova O., Bruss M., Staab T., Stober G., Riederer P., Bonisch H., and Lesch K.P. Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm. 105 (1998) 1341-1350
27. Netter P., and Vogel W.H. The effect of drinking habit on catecholamine and behavioral responses to stress and ethanol. Neuropsychobiology 24 (1990) 149-158
28. Nurnberger Jr. J.I., Wiegand R., Bucholz K., O'Connor S., Meyer E.T., Reich T., Rice J., Schuckit M., King L., Petti T., Bierut L., Hinrichs A.L., Kuperman S., Hesselbrock V., and Porjesz B. A family study of alcohol dependence: coaggregation of multiple disorders in relatives of alcohol-dependent probands. Arch. Gen. Psychiatry 61 (2004) 1246-1256
29. Owen D., Du L., Bakish D., Lapierre Y.D., and Hrdina P.D. Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res. 87 (1999) 1-5
30. Porzgen P., Bonisch H., and Bruss M. Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem. Biophys. Res. Commun. 227 (1996) 642-643
31. Preisig M., Merikangas K.R., and Angst J. Clinical significance and comorbidity of subthreshold depression and anxiety in the community. Acta Psychiatr. Scand. 104 (2001) 96-103
32. Rao D.C., and Province M.A. Genetic Dissection of Complex Traits (2001), Academic Press, San Diego
33. Reuster T., Buechler J., Winiecki P., and Oehler J. Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff's syndrome. Neuropsychopharmacology 28 (2003) 974-978
34. Ryu S.H., Lee S.H., Lee H.J., Cha J.H., Ham B.J., Han C.S., Choi M.J., and Lee M.S. Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology 49 (2004) 174-177
35. Samochowiec J., Kucharska-Mazur J., Kaminski R., Smolka M., Rommelschpacher H., Wernicke C., Tymicz A., and Schmidt L.G. Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res. 111 (2002) 229-233
36. Sand P.G., Mori T., Godau C., Stober G., Flachenecker P., Franke P., Nothen M.M., Fritze J., Maier W., Lesch K.P., Riederer P., Beckmann H., and Deckert J. Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci. Lett. 333 (2002) 41-44
37. Stober G., Nothen M.M., Porzgen P., Bruss M., Bonisch H., Knapp M., Beckmann H., and Propping P. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am. J. Med. Genet. 67 (1996) 523-532
38. Swendsen J.D., Merikangas K.R., Canino G.J., Kessler R.C., Rubio-Stipec M., and Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr. Psychiatry 39 (1998) 176-184
39. Uhl G.R., and Johnson P.S. Neurotransmitter transporters: three important gene families for neuronal function. J. Exp. Biol. 196 (1994) 229-236
40. Valverius P., Hogstrom-Brandt A.M., and Borg S. Norepinephrine metabolite in CSF correlates with ethanol consumption and heredity in humans. Alcohol 10 (1993) 499-503
41. Weinshenker D., Rust N.C., Miller N.S., and Palmiter R.D. Ethanol-associated behaviors of mice lacking norepinephrine. J. Neurosci. 20 (2000) 3157-3164
42. Weinshenker D., White S.S., Javors M.A., Palmiter R.D., and Szot P. Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo. Brain Res. 946 (2002) 239-246
43. Yoshida K., Takahashi H., Higuchi H., Kamata M., Ito K., Sato K., Naito S., Shimizu T., Itoh K., Inoue K., Suzuki T., and Nemeroff C.B. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am. J. Psychiatry 161 (2004) 1575-1580
44. Zhao J.H., Curtis D., and Sham P.C. Model-free analysis and permutation tests for allelic associations. Hum. Hered. 50 (2000) 133-139
45. Zhao J.H., and Sham P.C. Faster haplotype frequency estimation using unrelated subjects. Hum. Hered. 53 (2002) 36-41
46. Zill P., Engel R., Baghai T.C., Juckel G., Frodl T., Muller-Siecheneder F., Zwanzger P., Schule C., Minov C., Behrens S., Rupprecht R., Hegerl U., Moller H.J., and Bondy B. Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 26 (2002) 489-493
47. Zisook S., Rush A.J., Albala A., Alpert J., Balasubramani G.K., Fava M., Husain M., Sackeim H., Trivedi M., and Wisniewski S. Factors that differentiate early vs. later onset of major depression disorder. Psychiatry Res. 129 (2004) 127-140